Answers are grounded in this paper and cite their sources.
Observational study identifies occult nephropathies in patients undergoing radical nephrectomy, suggesting important clinical implications.
Background Chronic kidney disease and renal cell carcinoma share a bidirectional relationship, with radical nephrectomy posing a significant risk for post-operative renal decline. This study identifies radical nephrectomy as a critical opportunity to evaluate the non-neoplastic renal parenchyma. Methods We conducted a prospective observational study on 30 adult patients diagnosed with renal or urothelial cancer who underwent radical nephrectomy. Samples of non-neoplastic renal parenchyma were collected during surgery and analyzed using optical microscopy and immunofluorescence. Renal function was assessed pre-and post-operatively using the CKD-EPI formula. Results The cohort comprised 30 patients (63.3% male) with a median age of 65.5 years (min 29-max 83). Following radical nephrectomy, 50% of patients with preserved preoperative renal function experienced a decline to eGFR <60 ml/min/1.73m². Histopathological evaluation of the non-neoplastic parenchyma revealed chronic tubulointerstitial damage in 41% (n=12) and arteriosclerotic vascular damage in 38% (n=11) of cases. Notably, occult nephropathies were identified in 24% (n=7) of the cohort, comprising diabetic glomerulosclerosis (n=2), membranous nephropathy (n=2), fibrillary glomerulonephritis (n=1), IgA nephropathy (n=1), and minimal change disease (n=1). Two cases (IgA nephropathy and minimal change disease) demonstrated spontaneous remission post-surgery, consistent with a paraneoplastic etiology. Conclusions The non-neoplastic renal parenchyma in renal cell carcinoma patients frequently exhibits occult pathological changes, predominantly tubulointerstitial damage likely driven by the tumor microenvironment. The study highlights a higher-than-expected prevalence of undiagnosed nephropathies (24%), including paraneoplastic cases. Routine histological evaluation during radical nephrectomy is essential for optimizing patient management, avoiding unnecessary subsequent biopsies, and guiding therapeutic decisions in the oncological setting.
No takes yet. Share an insight, caveat, or question.
Fenoglio et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: